Sectoral Asset Management Inc Vertex Pharmaceuticals Inc Transaction History

Sectoral Asset Management Inc

  • $120 Million
  • Q3 2024

A detailed history of Sectoral Asset Management Inc transactions in Vertex Pharmaceuticals Inc stock. As of the latest transaction made, Sectoral Asset Management Inc holds 4,840 shares of VRTX stock, worth $1.98 Million. This represents 1.88% of its overall portfolio holdings.

Number of Shares
4,840
Previous 8,650 44.05%
Holding current value
$1.98 Million
Previous $4.05 Million 44.5%
% of portfolio
1.88%
Previous 2.01%

Shares

28 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024
SELL
$460.0 - $505.78 $1.75 Million - $1.93 Million
-3,810 Reduced 44.05%
4,840 $2.25 Million
Q2 2024

Aug 13, 2024
BUY
$392.81 - $485.53 $565,646 - $699,163
1,440 Added 19.97%
8,650 $4.05 Million
Q1 2024

May 14, 2024
SELL
$407.69 - $446.08 $819,049 - $896,174
-2,009 Reduced 21.79%
7,210 $3.01 Million
Q4 2023

Feb 14, 2024
BUY
$343.0 - $410.68 $154,350 - $184,806
450 Added 5.13%
9,219 $3.75 Million
Q3 2023

Nov 14, 2023
BUY
$338.18 - $362.46 $204,598 - $219,288
605 Added 7.41%
8,769 $3.05 Million
Q2 2023

Aug 11, 2023
BUY
$314.42 - $351.91 $485,778 - $543,700
1,545 Added 23.34%
8,164 $2.87 Million
Q1 2023

May 12, 2023
SELL
$283.23 - $323.1 $113,292 - $129,240
-400 Reduced 5.7%
6,619 $2.09 Million
Q4 2022

Feb 10, 2023
SELL
$285.76 - $321.48 $256,898 - $289,010
-899 Reduced 11.35%
7,019 $2.03 Million
Q3 2022

Nov 10, 2022
SELL
$273.83 - $305.53 $54,766 - $61,105
-200 Reduced 2.46%
7,918 $2.29 Million
Q2 2022

Aug 15, 2022
BUY
$234.96 - $292.55 $196,661 - $244,864
837 Added 11.5%
8,118 $2.29 Million
Q1 2022

May 10, 2022
SELL
$221.42 - $260.97 $108,495 - $127,875
-490 Reduced 6.31%
7,281 $1.9 Million
Q4 2021

Feb 11, 2022
SELL
$177.01 - $223.45 $345,169 - $435,727
-1,950 Reduced 20.06%
7,771 $1.71 Million
Q2 2021

Aug 16, 2021
SELL
$187.49 - $221.1 $299,984 - $353,760
-1,600 Reduced 14.13%
9,721 $1.96 Million
Q1 2021

May 14, 2021
SELL
$207.02 - $241.31 $1.16 Million - $1.35 Million
-5,600 Reduced 33.09%
11,321 $2.43 Million
Q4 2020

Feb 12, 2021
BUY
$207.01 - $276.09 $1.46 Million - $1.95 Million
7,050 Added 71.42%
16,921 $4 Million
Q3 2020

Nov 13, 2020
SELL
$255.65 - $303.1 $1.23 Million - $1.45 Million
-4,800 Reduced 32.72%
9,871 $2.69 Million
Q2 2020

Aug 13, 2020
SELL
$225.48 - $295.8 $338,220 - $443,700
-1,500 Reduced 9.28%
14,671 $4.26 Million
Q1 2020

May 13, 2020
BUY
$199.77 - $247.81 $19,977 - $24,781
100 Added 0.62%
16,171 $3.85 Million
Q4 2019

Feb 12, 2020
BUY
$166.71 - $223.91 $316,749 - $425,429
1,900 Added 13.41%
16,071 $3.52 Million
Q3 2019

Nov 14, 2019
SELL
$166.23 - $187.09 $3.92 Million - $4.42 Million
-23,600 Reduced 62.48%
14,171 $2.4 Million
Q2 2019

Aug 14, 2019
BUY
$164.61 - $190.37 $2.88 Million - $3.33 Million
17,500 Added 86.33%
37,771 $6.93 Million
Q1 2019

May 14, 2019
SELL
$163.73 - $194.7 $2.61 Million - $3.1 Million
-15,946 Reduced 44.03%
20,271 $3.73 Million
Q4 2018

Feb 12, 2019
SELL
$151.91 - $192.21 $6.17 Million - $7.81 Million
-40,629 Reduced 52.87%
36,217 $6 Million
Q3 2018

Nov 14, 2018
BUY
$167.73 - $192.74 $12.9 Million - $14.8 Million
76,846 New
76,846 $14.8 Million
Q2 2018

Aug 13, 2018
SELL
$145.72 - $169.96 $6.11 Million - $7.12 Million
-41,915 Closed
0 $0
Q1 2018

May 15, 2018
BUY
$151.6 - $177.13 $788,320 - $921,076
5,200 Added 14.16%
41,915 $6.83 Million
Q4 2017

Feb 13, 2018
BUY
$137.28 - $155.55 $372,715 - $422,318
2,715 Added 7.99%
36,715 $5.5 Million
Q3 2017

Nov 14, 2017
BUY
$148.13 - $162.24 $5.04 Million - $5.52 Million
34,000
34,000 $5.17 Million

Others Institutions Holding VRTX

# of Institutions
1,724
Shares Held
221M
Call Options Held
1.58M
Put Options Held
1.36M
View Full List

About VERTEX PHARMACEUTICALS INC

VRTX Quotes by TradingView
  • Ticker VRTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 256,691,008
  • Market Cap $105B
  • Description
  • Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with cystic fibrosis who have specific mutations in their cystic fibrosis transmembrane conductance regulator gene; and TRIKAF...
More about VRTX
Track This Portfolio

Track Sectoral Asset Management Inc Portfolio

Follow Sectoral Asset Management Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Sectoral Asset Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Sectoral Asset Management Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email